Evidence reveals that in ALI, supplementation with ACE-2 or inhibition of Ang-II improves outcomes and that a decrease in pulmonary ACE-2 and increase in Ang-II levels aggravate viral-induced ALI [60]. This evidence concerns the gene ACE2 and acute respiratory distress syndrome.